Past Medical History: Stage IV micropapillary transitional cell Ca of bladder with bil pelvic LAD and inguinal LAD *Presented with hematuria in [**2115**]-->cystoscopy revealed CIS treated wtih INF c/BCG completed [**4-12**] *Early [**2118**] rpt  cystoscopy showed grade IV transitional cell Ca bladder *S/P 4 cycles MVAC as neoadjuvant chemo *[**4-13**] radical cystoprostatectomy with 9/16 LN+ dz *Recurrence in pelivic and inguinal LN in [**9-14**] *Gemzar administered [**11-13**] to [**2121-1-10**] Local XRT to groin [**Date range (1) 34411**] *Taxol/gemzar [**2-13**]-->progressive dz (R hydro requiring stent) *Gemzar/oxaliplatin-->1st dose [**2121-5-29**] and last [**2121-7-17**] Scrotal edema and severe LE edema secondary to LAD as above DMII   Social History: Prior tobacco; quit 10 years ago No EtOH  Family History: Noncontributory  Physical Exam: 99.2  140/85  97  18  99RA FS113 200/550 Gen: Lying in bed in NAD HEENT: PERRL, MMM Chest: CTAB CV: No JVD, Nl S1/S2 Abdomen: Obese, NBS, mild right sided tenderness Ext: Warm X 4 with 2+ bil pitting edema to hip GU: Substantial scrotal edema and substanitial intretrigenous erythema Neuro: A&O X 4   Pertinent Results: CT abdomen: 1.
No evidence of obstruction  UA: 1.019, large blood, nitrite +, protein -, glucose -, mod leuks, 11-20RBC, 11-20WBCs, occasional bacteria  [**2121-8-19**] 04:30AM BLOOD WBC-14.8* RBC-3.17* Hgb-10.5* Hct-30.3* MCV-96 MCH-33.2* MCHC-34.7 RDW-16.7* Plt Ct-211 [**2121-8-11**] 07:43PM BLOOD WBC-9.9# RBC-3.53* Hgb-11.3* Hct-33.4* MCV-95 MCH-31.9 MCHC-33.8 RDW-16.7* Plt Ct-284# [**2121-8-16**] 04:21AM BLOOD Neuts-96* Bands-0 Lymphs-3* Monos-1* Eos-0 Baso-0 Atyps-0 Metas-0 Myelos-0 [**2121-8-11**] 07:43PM BLOOD Neuts-87.3* Lymphs-6.8* Monos-5.2 Eos-0.3 Baso-0.3 [**2121-8-19**] 04:30AM BLOOD Plt Ct-211 [**2121-8-19**] 04:30AM BLOOD PT-13.5 PTT-21.9* INR(PT)-1.2 [**2121-8-15**] 05:51AM BLOOD PT-14.2* PTT-20.3* INR(PT)-1.3 [**2121-8-11**] 07:43PM BLOOD PT-13.1 PTT-21.0* INR(PT)-1.1 [**2121-8-19**] 04:30AM BLOOD Fibrino-532* [**2121-8-17**] 05:43PM BLOOD Fibrino-549* D-Dimer-3155* [**2121-8-19**] 04:30AM BLOOD Glucose-128* UreaN-15 Creat-0.7 Na-140 K-3.9 Cl-103 HCO3-30* AnGap-11 [**2121-8-19**] 04:30AM BLOOD ALT-17 AST-20 AlkPhos-113 Amylase-39 TotBili-0.3 [**2121-8-18**] 05:00AM BLOOD ALT-22 AST-22 LD(LDH)-268* AlkPhos-121* Amylase-47 TotBili-0.4 [**2121-8-17**] 04:40AM BLOOD LD(LDH)-253* [**2121-8-11**] 07:43PM BLOOD ALT-122* AST-178* LD(LDH)-361* AlkPhos-364* Amylase-49 TotBili-0.5 [**2121-8-12**] 07:12AM BLOOD ALT-130* AST-178* LD(LDH)-351* AlkPhos-456* TotBili-0.5 [**2121-8-14**] 05:25AM BLOOD ALT-66* AST-47* AlkPhos-279* Amylase-36 TotBili-0.4 [**2121-8-19**] 04:30AM BLOOD Lipase-19 [**2121-8-11**] 07:43PM BLOOD Lipase-23 [**2121-8-19**] 04:30AM BLOOD Calcium-8.6 Phos-2.2* Mg-2.1 [**2121-8-19**] 04:30AM BLOOD Hapto-296* [**2121-8-17**] 04:40AM BLOOD Hapto-261* [**2121-8-14**] 05:25AM BLOOD Osmolal-268* [**2121-8-13**] 04:52AM BLOOD TSH-1.1 [**2121-8-13**] 04:52AM BLOOD Cortsol-27.9* [**2121-8-16**] 06:15AM BLOOD Type-ART Rates-/11 Tidal V-1000 PEEP-5 O2-60 pO2-146* pCO2-35 pH-7.49* calHCO3-27 Base XS-4 Intubat-INTUBATED Vent-SPONTANEOU [**2121-8-15**] 04:19PM BLOOD Type-ART Temp-36.2 Rates-/12 Tidal V-700 PEEP-5 O2-100 pO2-318* pCO2-39 pH-7.45 calHCO3-28 Base XS-3 AADO2-378 REQ O2-65 Intubat-INTUBATED Vent-CONTROLLED [**2121-8-15**] 04:19PM BLOOD Glucose-174* Lactate-2.1* Na-129* K-3.3* Cl-98* [**2121-8-15**] 04:19PM BLOOD freeCa-1.20  Brief Hospital Course: This 55 yo man with transitional cell carcinoma of the bladder was admitted with abdominal pain, UTI, and elevated transaminases.
Abdominal pain- The pain was concerning for progression of the patients disease, although CT scan was negative.
His elevated LFTs led to RUQ US which demonstrated a CBD of 1.5cm; ERCP attempts failed, but the pain has subsided with agressive bowel regimen resulting in bowel movements.
The patient's neobladder had raised worry of perforation, but CT scan was negative for this.
Increased LFTs- As above, the LFTs prompted RUQ ultrasound which revealed a dilated CBD.
Pain- Patient was placed on PCA with 10mg basal rate and 1mg Q6, representing a slight decrease to his equianalgesic dosing of 320 oxycontin tid with variable oxycodone dosing for breakthrough.
If you experience shortness of breath, chest pain, abdominal pain, nausea, vomitting, diarrhea or constipation, call your doctor or return to the emergency room.
[**First Name4 (NamePattern1) 2946**] [**Last Name (NamePattern1) **] MD [**MD Number(1) 3218**]
